Ajanta Pharma Limited | AJANTPHARM | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
6,482
6,226
5,143
6,640
9,002
Cash flow Operating Act...
Cash flow Operating Activities
6,0812,8543,7484,5685,763
Investments in PPE
Investments in PPE
-3,015-2,627-3,430-2,394-1,716
Cash flow Investing Act...
Net cash used for Investment Activities
-3,908-2,604-2,228-2,244-2,824
Dividend Paid
Dividend Paid
1,28737951,159829
Cash flow Financing Act...
Net cash provided by Financing Activities
-2,068-2-1,475-1,286-3,183
Cash at beginning of period
Cash at beginning of period
4146589069522,024
Cash at end of period
Cash at end of period
5199069521,9891,780
Free Cash Flow
Free Cash Flow
3,066
227
318
2,174
4,047